Dear Colleagues,

Genital malignancy is currently one of the leading causes of death in women. Prevention and early detection through the application of organized screening programs can substantially contribute to reducing cancer morbidity and mortality. The purpose of this Special Issue is to improve the long-term prognosis of patients and to increase the quality of life of both patients with genital neoplasm and their survivors, families, and caregivers. The continuous development of science in cancer has led to the discovery and implementation of new innovative therapies. In particular, accurate investigations of various physical phenomena occurring in human systems through experimental, theoretical, and computational biomechanics tools are recognized as essential technologies to realize personalized medicine. Additionally, drug targeting draws attention to different therapies’ applications, thanks to their functions to guide and control their interaction with specific target molecules, cells, and tissues. Through this Special Issue, we invite practitioners to share their experiences with the medical world, which could ultimately lead to a collection of information that would improve the approach and treatment of patients. Original research manuscripts, short communications of preliminary but significant results, reviews, and case reports that could contribute to the achievement of the purpose are welcome.

Prof. Dr. Marius L. Craina
Dr. Elena Bernad
Dr. Sandor Bernad
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• genital neoplasm
• breast neoplasm
• diagnosis
• surgery
• drug therapy
• drug targeting
• computational biomechanics
• litigation